Company registration number 03691473 (England and Wales)
JOLINDA MEDICAL SUPPLIES LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
PAGES FOR FILING WITH REGISTRAR
JOLINDA MEDICAL SUPPLIES LTD
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 5
JOLINDA MEDICAL SUPPLIES LTD
BALANCE SHEET
AS AT
31 MARCH 2025
31 March 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
3
779
1,344
Current assets
Stocks
94,646
96,582
Debtors
4
291,440
320,624
Cash at bank and in hand
528,250
402,829
914,336
820,035
Creditors: amounts falling due within one year
5
(130,876)
(113,390)
Net current assets
783,460
706,645
Total assets less current liabilities
784,239
707,989
Provisions for liabilities
(148)
(242)
Net assets
784,091
707,747
Capital and reserves
Called up share capital
1,098
1,098
Profit and loss reserves
782,993
706,649
Total equity
784,091
707,747

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

JOLINDA MEDICAL SUPPLIES LTD
BALANCE SHEET (CONTINUED)
AS AT
31 MARCH 2025
31 March 2025
- 2 -
The financial statements were approved by the board of directors and authorised for issue on 2 September 2025 and are signed on its behalf by:
Mr Barry Mickler
Mrs Melanie Mickler
Director
Director
Company Registration No. 03691473
JOLINDA MEDICAL SUPPLIES LTD
BALANCE SHEET (CONTINUED)
AS AT 31 MARCH 2025
31 March 2025
- 3 -
1
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
2
2
2
Accounting policies
Company information

Jolinda Medical Supplies Ltd is a private company limited by shares incorporated in England and Wales. The registered office is 3a Chestnut House, Farm Close, Shenley, Hertfordshire, United Kingdom, WD7 9AD.

2.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

2.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

2.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures and fittings
25% on cost

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

2.4
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell, after making allowance for obsolete and slow moving stock.

2.5
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

JOLINDA MEDICAL SUPPLIES LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
2
Accounting policies
(Continued)
- 4 -
Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

2.6
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

2.7
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

JOLINDA MEDICAL SUPPLIES LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 5 -
3
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 April 2024
9,601
Disposals
(7,037)
At 31 March 2025
2,564
Depreciation and impairment
At 1 April 2024
8,257
Depreciation charged in the year
565
Eliminated in respect of disposals
(7,037)
At 31 March 2025
1,785
Carrying amount
At 31 March 2025
779
At 31 March 2024
1,344
4
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
81,776
86,647
Other debtors
209,664
233,977
291,440
320,624
5
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
86,252
68,170
Corporation tax
35,097
27,764
Other taxation and social security
8,626
13,984
Other creditors
901
3,472
130,876
113,390
2025-03-312024-04-01falsefalsefalse02 September 2025CCH SoftwareCCH Accounts Production 2025.200No description of principal activityMr B MicklerMrs Melanie Mickler036914732024-04-012025-03-31036914732025-03-31036914732024-03-3103691473core:OtherPropertyPlantEquipment2025-03-3103691473core:OtherPropertyPlantEquipment2024-03-3103691473core:CurrentFinancialInstrumentscore:WithinOneYear2025-03-3103691473core:CurrentFinancialInstrumentscore:WithinOneYear2024-03-3103691473core:CurrentFinancialInstruments2025-03-3103691473core:CurrentFinancialInstruments2024-03-3103691473core:ShareCapital2025-03-3103691473core:ShareCapital2024-03-3103691473core:RetainedEarningsAccumulatedLosses2025-03-3103691473core:RetainedEarningsAccumulatedLosses2024-03-3103691473bus:Director12024-04-012025-03-3103691473bus:Director22024-04-012025-03-31036914732023-04-012024-03-3103691473core:FurnitureFittings2024-04-012025-03-3103691473core:OtherPropertyPlantEquipment2024-03-3103691473core:OtherPropertyPlantEquipment2024-04-012025-03-3103691473core:WithinOneYear2025-03-3103691473core:WithinOneYear2024-03-3103691473bus:PrivateLimitedCompanyLtd2024-04-012025-03-3103691473bus:SmallCompaniesRegimeForAccounts2024-04-012025-03-3103691473bus:FRS1022024-04-012025-03-3103691473bus:AuditExemptWithAccountantsReport2024-04-012025-03-3103691473bus:FullAccounts2024-04-012025-03-31xbrli:purexbrli:sharesiso4217:GBP